News

Article

Pharmaceutical Technology

Pharmaceutical Technology-10-15-2020
Volume2020 eBook
Issue 3
Pages: 42–44

Tackling Cybersecurity Challenges in Legacy Systems

Ongoing and emerging cyber-risks to legacy operational technology systems in bio/pharmaceutical manufacturing must be addressed.

As bio/pharma manufacturers make their operations and networks increasingly streamlined and interconnected, there is a need to connect older facilities to the supply chain. In turn, this means that operational technology (OT) cybersecurity measures must be introduced to legacy systems to support archaic equipment, older operating systems, and decades-old protocols as well as networks where it is not possible to fully monitor the operational network or to detect and control intrusions.

Read this article in Pharmaceutical Technology's Regulatory Sourcebook October 2020 eBook.

Article Details

Pharmaceutical Technology
eBook: Regulatory Sourcebook, October 2020
October 2020
Pages: 42–44

Citation

When referring to this article, please cite it as R. Brokamp and A. Karisik, “Tackling Cybersecurity Challenges in Legacy Systems," Pharmaceutical Technology Regulatory Sourcebook (October 2020).

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Behind the Headlines Episode 25
© 2025 MJH Life Sciences

All rights reserved.